HARVARD BIOSCIENCE INC — Director's Dealing 2014

Feb 12, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-12-31

Reporting Person: LEWIS EARL R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-06	Common Stock	M	10000	$3.00	Acquired	161455	Direct
2013-09-06	Common Stock	M	36000	$3.18	Acquired	161455	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-06	Stock option (right to buy)	$3.00	M	10000	Disposed	2015-05-26	Common stock, par value $0.01 per share (10000)	Direct
2013-09-06	Stock option (right to buy)	$3.18	M	36000	Disposed	2019-05-21	Common stock, par value $0.01 per share (36000)	Direct

Footnotes

F1: Based on holdings as of December 31, 2013, including these shares acquired as evidenced by the transactions reported on Table I of this Form 5 as well as transactions occuring thereafter on or prior to December 31, 2013, and includes (a) a deferred stock award of 7,777 restricted stock units which shall fully vest on May 31, 2014; (b) a deferred stock award of 7,377 restricted stock units which vest in equal installments on June 1, 2014 and June 1, 2015; and (c) 146,301 shares of common stock held by the Reporting Person.

F2: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan.